<bill session="116" type="h" number="2009" updated="2022-11-01T18:47:25Z">
  <state datetime="2019-04-01">REFERRED</state>
  <status>
    <introduced datetime="2019-04-01"/>
  </status>
  <introduced datetime="2019-04-01"/>
  <titles>
    <title type="display">Removing Barriers to Allergy Diagnostic Testing Act of 2019</title>
    <title type="official" as="introduced">To amend titles XVIII and XIX of the Social Security Act to provide equal coverage of in vitro specific IgE tests and percutaneous tests for allergies under the Medicare and Medicaid programs, and for other purposes.</title>
    <title type="short" as="introduced">Removing Barriers to Allergy Diagnostic Testing Act of 2019</title>
  </titles>
  <sponsor bioguide_id="C001067"/>
  <cosponsors>
    <cosponsor bioguide_id="B001303" joined="2020-09-29"/>
    <cosponsor bioguide_id="B001278" joined="2019-04-25"/>
    <cosponsor bioguide_id="B001251" joined="2020-09-29"/>
    <cosponsor bioguide_id="D000197" joined="2020-11-17"/>
    <cosponsor bioguide_id="E000179" joined="2019-04-12"/>
    <cosponsor bioguide_id="G000581" joined="2019-04-25"/>
    <cosponsor bioguide_id="H001047" joined="2019-06-18"/>
    <cosponsor bioguide_id="J000292" joined="2019-05-15"/>
    <cosponsor bioguide_id="K000391" joined="2019-04-12"/>
    <cosponsor bioguide_id="M001187" joined="2019-05-01"/>
    <cosponsor bioguide_id="M001206" joined="2019-06-19"/>
    <cosponsor bioguide_id="M001196" joined="2019-04-09"/>
    <cosponsor bioguide_id="P000608" joined="2019-04-09"/>
    <cosponsor bioguide_id="P000607" joined="2019-04-10"/>
    <cosponsor bioguide_id="R000606" joined="2019-04-09"/>
    <cosponsor bioguide_id="R000515" joined="2019-04-04"/>
    <cosponsor bioguide_id="T000469" joined="2020-09-30"/>
    <cosponsor bioguide_id="U000031" joined="2019-04-01"/>
    <cosponsor bioguide_id="V000131" joined="2020-11-19"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-04-01" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-01">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-04-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="2246" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Allergies"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Medicaid"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2020-06-02T18:18:50Z" status="Introduced in House">Removing Barriers to Allergy Diagnostic Testing Act of 2019

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.</summary>
</bill>
